Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-09-23
2009-10-27
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S350000
Reexamination Certificate
active
07608622
ABSTRACT:
The invention is directed to compounds of Formula I:wherein Q, Y, A are set forth in the specification, as well as solvates, hydrates, tautomers or pharmaceutically acceptable salts thereof, that inhibit protein kinases, especially Aurora-1, Aurora-2 and Aurora-3 kinases.
REFERENCES:
patent: 2400101 (2004-10-01), None
Dorwald F. A. Side Reactions in Organic Synthesis, 2005, Wiley: VCH, Weinheim p. IX of Preface.
Vippagunta et. al. Advanced Drug Delivery Reviews 48 (2001) 3-26.
International Search Report re: PCT/US05/34395 dated May 3, 2006.
Hu Huaping
Liu Jian
Patch Raymond J.
Player Mark R.
Janssen Pharmaceutica NV
Murray Jeffrey H
Wilson James O
LandOfFree
Imidazo[4,5- b ]pyrazinone inhibitors of protein kinases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazo[4,5- b ]pyrazinone inhibitors of protein kinases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazo[4,5- b ]pyrazinone inhibitors of protein kinases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4133959